MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, BCRX has $465,052K in assets. $1,018,895K in debts. $171,591K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
191.22%
Quick Ratio
188.16%
Cash Ratio
87.82%
Debt to Asset Ratio
219.09%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Trade receivables
    • Short-term investments
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Royalty financing obligations
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
171,591 89,736 84,078 88,033
Restricted cash
854 201 579 492
Short-term investments
66,809 185,011 128,795 172,005
Trade receivables
109,272 106,818 91,325 91,177
Inventory, net
5,985 5,398 5,232 5,044
Prepaid expenses and other current assets
19,114 17,182 16,502 12,541
Current assets held for sale-Disposal Group Heldforsale Not Discontinued Operations
--29,173 29,170
Total current assets
373,625 404,346 355,684 398,462
Long-term inventory, net
28,176 23,990 23,390 22,205
Property and equipment, net
9,368 8,783 8,396 8,457
Long-term investments
20,569 61,164 39,669 10,101
Right of use assets, net
13,617 10,203 10,840 11,546
Other assets
19,697 5,672 4,387 3,592
Non-current assets held for sale-Disposal Group Heldforsale Not Discontinued Operations
--4,058 2,825
Total assets
465,052 514,158 446,424 457,188
Accounts payable
10,958 15,826 5,567 8,589
Accrued expenses
119,398 126,413 118,778 107,114
Share-based liability
16,216 13,743 --
Operating lease liabilities
1,858 317 348 392
Finance lease liabilities
1,235 1,312 1,435 1,616
Royalty financing obligations
40,317 38,455 37,686 35,741
Current liabilities held for sale-Disposal Group Heldforsale Not Discontinued Operations
--26,423 23,708
Deferred revenue
5,409 ---
Total current liabilities
195,391 196,066 190,237 177,160
Operating lease liabilities
11,122 8,571 8,425 8,489
Finance lease liabilities
1,173 1,441 1,742 2,043
Royalty financing obligations
407,181 427,233 439,107 447,842
Secured term loan
395,197 0 194,366 242,794
Non-current liabilities held for sale-Disposal Group Heldforsale Not Discontinued Operations
--436 454
Deferred revenue
8,831 ---
Total liabilities
1,018,895 633,311 834,313 878,782
Common stock, 0.01 par value shares authorized - 450,000 shares issued and outstanding 254,014 at march31, 2026 and 213,060 at december31, 2025
2,540 2,131 2,105 2,099
Additional paid-in capital
1,671,976 1,384,857 1,360,890 1,339,584
Accumulated other comprehensive (loss) income
-368 38 1,140 1,646
Accumulated deficit
-2,227,991 -1,506,179 -1,752,024 -1,764,923
Total stockholders deficit
-553,843 -119,153 -387,889 -421,594
Total liabilities and stockholders deficit
465,052 514,158 446,424 457,188
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$171,591K (63.12%↑ Y/Y)Trade receivables$109,272K (17.00%↑ Y/Y)Short-term investments$66,809K (-64.82%↓ Y/Y)Prepaid expenses andother current assets$19,114K (33.41%↑ Y/Y)Inventory, net$5,985K (-12.92%↓ Y/Y)Restricted cash$854K (193.47%↑ Y/Y)Total current assets$373,625K (-8.87%↓ Y/Y)Long-term inventory, net$28,176K (12.27%↑ Y/Y)Long-term investments$20,569K (0.10%↑ Y/Y)Other assets$19,697K (306.12%↑ Y/Y)Right of use assets,net$13,617K (13.65%↑ Y/Y)Property and equipment,net$9,368K (23.38%↑ Y/Y)Total assets$465,052K (-3.12%↓ Y/Y)Accumulated deficit-$2,227,991K (-25.87%↓ Y/Y)Accumulated othercomprehensive (loss) income-$368K (-132.51%↓ Y/Y)Total liabilities andstockholders deficit$465,052K (-3.12%↓ Y/Y)Total stockholdersdeficit-$553,843K (-22.55%↓ Y/Y)Additional paid-in capital$1,671,976K (27.16%↑ Y/Y)Common stock, 0.01 parvalue shares...$2,540K (21.41%↑ Y/Y)Total liabilities$1,018,895K (9.33%↑ Y/Y)Royalty financingobligations$407,181K (-12.74%↓ Y/Y)Secured term loan$395,197K (25.30%↑ Y/Y)Total currentliabilities$195,391K (39.71%↑ Y/Y)Operating leaseliabilities$11,122K (42.97%↑ Y/Y)Deferred revenue$8,831K Finance leaseliabilities$1,173K (-49.31%↓ Y/Y)Accrued expenses$119,398K (28.89%↑ Y/Y)Royalty financingobligations$40,317K (17.53%↑ Y/Y)Share-based liability$16,216K Accounts payable$10,958K (9.05%↑ Y/Y)Deferred revenue$5,409K Operating leaseliabilities$1,858K (73.48%↑ Y/Y)Finance leaseliabilities$1,235K (-31.20%↓ Y/Y)

BIOCRYST PHARMACEUTICALS INC (BCRX)

BIOCRYST PHARMACEUTICALS INC (BCRX)